JAK2

An Ocean of Hope For MPN Research

September 12, 2013
Editor’s note: This post has been edited from its original to reflect changes in 23andMe’s product. We’re posting a story about one of the participants in 23andMe’s MPN Research Initiative...
Read More

Top Genetic Findings of 2012

December 20, 2012
Take a moment to look back at the ten most interesting and significant genetic findings of 2012 or at least the ones that drew our attention. In the last 12...
Read More

New Discoveries about Rare Blood Disorders from 23andMe

December 06, 2012
Earlier this year we met our goal of enrolling 1,000 people in a community of people with a collection of rare blood disorders known as myeloproliferative neoplasms, or MPNs. Since...
Read More

Fighting Rare Blood Cancers

September 04, 2012
Dr. Ross Levine Last year 23andMe launched a Myeloproliferative Neoplasms Research Initiative to study this group of rare blood cancers. We are now very close to reaching our goal of...
Read More

SNPwatch: The Jist on JAK2 and Myeloproliferative Neoplasms

March 05, 2012
Myeloproliferative neoplasms (MPN) are a group of rare blood disorders. First characterized in 1951, it wasn't until 2005 that researchers began to uncover clues about the genetic basis of these diseases. An acquired mutation called V617F in the JAK2 gene is present in many people with MPN, and a growing body of research -- including evidence in 23andMe's MPN research cohort -- suggests that relatively common inherited genetic variants may predispose individuals to V617F-positive MPN.
Read More

SNPwatch: Inherited Genetic Variation May Predispose People For Blood Disorder Mutation Later in Life

March 16, 2009
Editor’s note: This post has been edited from its original to reflect changes in 23andMe’s product. Sometimes you can have too much of a good thing. Stem cells in your...
Read More